Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.54%44.89B | 12.17%45.13B | 7.51%11.09B | 9.78%12.06B | 5.77%10.1B | 26.60%11.88B | 14.26%40.23B | 13.64%10.32B | 10.76%10.99B | 21.38%9.55B |
| Cost of revenue | 0.87%39.57B | 15.03%39.22B | 9.55%9.7B | 11.43%10.59B | 8.74%8.78B | 32.45%10.15B | 15.34%34.1B | 13.51%8.85B | 13.10%9.5B | 24.47%8.08B |
| Gross profit | -9.91%5.32B | -3.72%5.91B | -4.80%1.4B | -0.78%1.47B | -10.59%1.31B | 0.51%1.73B | 8.63%6.14B | 14.39%1.47B | -2.20%1.49B | 6.75%1.47B |
| Operating expense | -4.72%3.78B | 17.89%3.96B | 7.82%1B | -1.05%856.41M | 20.97%984.81M | 48.83%1.12B | 9.85%3.36B | 3.32%930.16M | -5.31%865.52M | 33.83%814.11M |
| Operating profit | -20.49%1.55B | -29.92%1.94B | -26.64%394.18M | -0.40%617.61M | -49.94%326.89M | -37.16%606.07M | 7.19%2.77B | 40.44%537.29M | 2.52%620.1M | -14.75%653M |
| Net non-operating interest income (expenses) | 29.84%83.99M | 16.15%64.69M | 130.32%29.57M | -24.66%10.84M | -23.29%10.9M | -6.16%13.38M | -11.75%55.69M | -31.84%12.84M | 15.22%14.39M | -13.17%14.21M |
| Non-operating interest income | 31.83%98.49M | 16.14%74.71M | 113.11%32.18M | -20.61%13.06M | -19.99%13.12M | -0.18%16.35M | -7.80%64.33M | -26.58%15.1M | 17.41%16.45M | -9.22%16.4M |
| Non-operating interest expense | 44.61%14.5M | 16.05%10.03M | 15.38%2.61M | 7.65%2.22M | 1.46%2.22M | 39.92%2.98M | 29.52%8.64M | 30.60%2.26M | 35.30%2.07M | 28.91%2.19M |
| Net investment income | 17.62%240.38M | 20.93%204.36M | 36.80%922K | 16.27%43.71M | 3.90%2.64M | 22.55%157.09M | 15.32%169M | 8.89%674K | 5.32%37.59M | 2.17%2.54M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 14.82M | 0 | ||||||||
| Income from associates and other participating interests | 150.77%37.67M | 985.33%15.02M | 23.82%13.43M | 63.56%-3.79M | 339.58%2.3M | 62.22%3.08M | -93.67%1.38M | 224.21%10.85M | -2,172.11%-10.4M | -266.09%-960K |
| Special income (charges) | 89.51%-3.45M | -510.99%-3.45M | 0 | -169.05%-32.84M | 84.24%-564K | 0 | -158.89%-22.34M | |||
| Less:Other special charges | ---- | -89.51%3.45M | ---- | ---- | ---- | ---- | 817.92%32.84M | --564K | --0 | --22.34M |
| Other non-operating income (expenses) | 32.56%196.83M | 65.97%148.48M | 75.71%46.84M | 12.06%15.91M | 16.20%30.19M | 145.46%55.55M | 12.09%89.46M | -14.68%26.66M | -33.58%14.2M | 123.27%25.98M |
| Income before tax | -10.82%2.12B | -22.25%2.38B | -17.49%484.94M | 1.24%684.28M | -44.54%372.92M | -25.53%835.17M | 8.99%3.06B | 35.73%587.74M | 0.14%675.88M | -14.71%672.42M |
| Income tax | -5.11%704.26M | -1.15%742.22M | -29.11%155.49M | 32.92%181.56M | -15.24%124.45M | 13.13%280.72M | -6.95%750.89M | 45.69%219.33M | -16.64%136.6M | -40.12%146.83M |
| Net income | -13.42%1.42B | -29.11%1.64B | -10.57%329.45M | -6.78%502.72M | -52.73%248.47M | -36.52%554.45M | 15.43%2.31B | 30.42%368.41M | 5.52%539.28M | -3.25%525.59M |
| Net income continuous operations | -13.42%1.42B | -29.11%1.64B | -10.57%329.45M | -6.78%502.72M | -52.73%248.47M | -36.52%554.45M | 15.43%2.31B | 30.42%368.41M | 5.52%539.28M | -3.25%525.59M |
| Noncontrolling interests | 3.41%364K | 5.07%352K | 44.74%55K | 44.09%134K | -19.63%86K | -20.62%77K | -7.97%335K | -11.63%38K | 0.00%93K | -19.55%107K |
| Net income attributable to the company | -13.42%1.42B | -29.12%1.63B | -10.58%329.4M | -6.79%502.59M | -52.73%248.38M | -36.52%554.37M | 15.43%2.31B | 30.42%368.37M | 5.52%539.19M | -3.24%525.48M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -13.42%1.42B | -29.12%1.63B | -10.58%329.4M | -6.79%502.59M | -52.73%248.38M | -36.52%554.37M | 15.43%2.31B | 30.42%368.37M | 5.52%539.19M | -3.24%525.48M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -13.51%115.64 | -29.19%133.7 | -10.65%26.93 | -6.84%41.1 | -52.80%20.3 | -36.58%45.37 | 15.31%188.81 | 30.31%30.14 | 5.40%44.12 | -3.35%43.01 |
| Diluted earnings per share | -13.51%115.64 | -29.19%133.7 | -10.65%26.93 | -6.86%41.0925 | -52.80%20.3 | -36.58%45.37 | 15.31%188.81 | 30.31%30.14 | 5.40%44.12 | -3.34%43.0069 |
| Dividend per share | 0.00%17 | 41.67%17 | 41.67%17 | 0 | 0 | 0 | 0.00%12 | 0.00%12 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |